Author, Subjects, Keywords

Cited Author

 
 
   » By Author or Editor
 » Browse Author by Alphabet
 » By Journal
 » By Subjects
 » By Affiliations
 » By Type
 » By Year
 » By Latest Additions
 
 
   » By Author
 » Top 20 Authors
 » Top 20 Article
 » Top 20 Journal Cited
 » Top 20 Cited
 » Top 20 Author Cited
 » Usage Since Sept 2007


 
 
 

Login | Create Account

Dyslipidaemic Pattern Of Patients With Type 2 Diabetes Mellitus.

Eid, M. and Mafauzy Mohamed, and Faridah Abdul Rashid, and Faridah, A.R. Use Faridah Abdul Rashid (2004) Dyslipidaemic Pattern Of Patients With Type 2 Diabetes Mellitus. Malaysian Journal of Medical Sciences, 11 (1). pp. 44-51. ISSN 1394195X

Full text not available from this repository.

Official URL: http://www.medic.usm.my/publication/mjms

Affiliations

Universiti Sains Malaysia, School of Medical Sciences, Dept. of Chemical Pathology
Universiti Sains Malaysia, School of Medical Sciences, Dept. of Medicine

Abstract

The aim of the study was to define dyslipidaemic pattern among type 2 diabetic patients using American Diabetes Association guidelines for the classification of lipoprotein concentrations into CVD risk categories. The total number screened was 211 type 2 diabetic patients who were on treatment between 2001 – 2002 for diabetes at the Outpatient Diabetes Clinic in HUSM Kubang Kerian. Fasting venous blood samples were analysed for plasma glucose, glycated hemoglobin and serum lipids. Type 2 diabetic patients with high, borderline, and low risk LDL cholesterol level were 62 %, 25 %, and 10 %, respectively. There were 26 % patients in the high risk HDL cholesterol group, 31 % were in the borderline risk group, and 43% were in the low risk group. Only 3 % and 25 % of patients had triglycerides concentration in the high and borderline risk categories, respectively, but 72% had low risk triglycerides levels. More female and younger subjects than men and older subjects had HDL cholesterol in high and borderline risk categories. The percentages of patients with triglycerides values at high and borderline high risk category were higher in poor and acceptable glycaemic control groups than good glycaemic control group. The most prevalent dyslipidaemia pattern was an isolated LDL cholesterol increase, which was observed in 35 % of the patients. The second most common pattern of dyslipidaemia was a combination of LDL cholesterol above goal with HDL cholesterol below target, which was observed in 30 % patients. Patients with established dyslipidaemia will require advice regarding diet, exercise and improvement in glycaemic control. An active strategy of early detection and drug treatment for dyslipidaemia is needed for type 2 diabetic patients.

Item Type:Journal
Keywords:Dyslipidaemia, Type 2 Diabetes, Kencing manis
Subjects:R Medicine
ID Code:627

1. Koskinen P, Manttari M, Manninen V, Huttunen J.K, Heinonen O.P, & Frick M.H. Coronary heart disease incidence in NIDDM patients in the Helsinki Heart

Study. Diabetes Care 1992; 15 (7): 820 – 825.

2. Laakso M, Lehto S, Penttila I & Pyorala K. Lipids and

lipoproteins predicting coronary heart disease mortality

and morbidity in patients with non-insulin-dependent

diabetes. Circulation 1993; 88: 1421 – 1430.

3. Manninen V, Tenkanen L, Koskinen P, Huttunen J.K, Manttari M, Heinonen O.P & Frick M.H. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment. Circulation 1992; 85 (1): 37 – 45.

4. Howard B.V, Robbins D.C, Sievers M.L, Lee E.T, Rhoades D, Devereux R.B, Cowan, L.D, Gray R.S, Welty T.K, Go O.T, & Howard W.J. LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL: the Strong Heart Study. Arterioscler Thromb Vasc Biol 2000; 20: 830 – 835.

5. Grundy S.M. Small LDL, atherogenic dyslipidemia, and the metabolic syndrome (Editorial). Circulation 1997; 95 (1): 1 – 4.

6. Grundy S.M, Benjamin I.J, Burke G.L, Chait A, Eckel R.H, Howard B.V, Mitch, W, Smith S.C, & Sowers J.R.

Diabetes and cardiovascular disease: a statement for

healthcare professionals from the American Heart

Association. Circulation 1999; 100: 1134 – 1146.

7. Primatesta P & Poulter N.R. Lipid concentrations and

the use of lipid lowering drugs: evidence from a national cross sectional survey. BMJ 2000; 321: 1322– 1325.

8. Henry R.R. Preventing Cardiovascular Complications

of Type 2 Diabetes: Focus on Lipid Management.

Clinical Diabetes 2001; 19 (3): 113 – 120.

9. American Diabetes Association. Management of dyslipidaemia in adults with diabetes (Position Statement). Diabetes Care 2002; 25 (Suppl. 1): S74 –S77.

10. American Diabetes Association. Standards of Medical

Care for Patients With Diabetes Mellitus (Position Statement). Diabetes Care 2002; 25 (1): 213 – 229.

11. The National Cholesterol Education Program (NCEP).

Executive summary of the third report of the National

Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285 (19): 2486 – 2497.

12. Cook C.B, Erdman D.M, Ryan G.J, Greenlund K.J, Giles W.H, Gallina D.L, El-kebbi I.M, Ziemer D.C, Ernst K.L,

Dunbar V.G, & Phillips L.S. The Pattern of dyslipidemia

among urban African-Americans with type 2 diabetes. Diabetes Care 2000; 23 (3):319 – 324.

13. IS Ismail, W Nazaimoon, W Mohamad et al. Ethnicity

and glycaemic control are major determinants of diabetic dyslipidaemia in Malaysia. Diabetic Medicine 2001; 18: 501 – 508.

Repository Staff Only: item control page
 
 
 
 
 
   
© Copyright 2007 MyAIS Faculty of Computer Science and Information Technology, University of Malaya – All Rights Reserved. Malaysian Abstracting and Indexing System is powered by EPrints 3 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.